GB202016957D0 - Beneficial treatment - Google Patents
Beneficial treatmentInfo
- Publication number
- GB202016957D0 GB202016957D0 GBGB2016957.9A GB202016957A GB202016957D0 GB 202016957 D0 GB202016957 D0 GB 202016957D0 GB 202016957 A GB202016957 A GB 202016957A GB 202016957 D0 GB202016957 D0 GB 202016957D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- beneficial treatment
- beneficial
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (12)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2016957.9A GB202016957D0 (en) | 2020-10-26 | 2020-10-26 | Beneficial treatment |
MX2022013884A MX2022013884A (en) | 2020-05-05 | 2021-04-30 | Methylthioninium compounds for use in the treatment of hypoxemia. |
US17/922,886 US20230158040A1 (en) | 2020-05-05 | 2021-04-30 | Methylthioninium compounds for use in the treatment of hypoxemia |
CA3181388A CA3181388A1 (en) | 2020-05-05 | 2021-04-30 | Methylthioninium compounds for use in the treatment of hypoxemia |
EP21724580.2A EP4146225A1 (en) | 2020-05-05 | 2021-04-30 | Methylthioninium compounds for use in the treatment of hypoxemia |
PCT/EP2021/061485 WO2021224146A1 (en) | 2020-05-05 | 2021-04-30 | Methylthioninium compounds for use in the treatment of hypoxemia |
JP2022567338A JP2023524146A (en) | 2020-05-05 | 2021-04-30 | Methylthioninium compounds used to treat hypoxemia |
KR1020227042296A KR20230012515A (en) | 2020-05-05 | 2021-04-30 | beneficial treatment methods |
AU2021268465A AU2021268465A1 (en) | 2020-05-05 | 2021-04-30 | Methylthioninium compounds for use in the treatment of hypoxemia |
CN202180043776.XA CN115916211A (en) | 2020-05-05 | 2021-04-30 | Methylthioninium compounds for the treatment of hypoxemia |
BR112022022322A BR112022022322A2 (en) | 2020-05-05 | 2021-04-30 | METHYLTHIONIUM COMPOUNDS FOR USE IN THE TREATMENT OF HYPOXEMIA |
TW110116178A TW202200149A (en) | 2020-05-05 | 2021-05-05 | Beneficial treatment |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2016957.9A GB202016957D0 (en) | 2020-10-26 | 2020-10-26 | Beneficial treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202016957D0 true GB202016957D0 (en) | 2020-12-09 |
Family
ID=73727053
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2016957.9A Ceased GB202016957D0 (en) | 2020-05-05 | 2020-10-26 | Beneficial treatment |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202016957D0 (en) |
-
2020
- 2020-10-26 GB GBGB2016957.9A patent/GB202016957D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB202108224D0 (en) | Treatment | |
GB202116743D0 (en) | Treatment | |
GB202103122D0 (en) | Treatment | |
GB202016058D0 (en) | Therapeautic treatment | |
GB202003722D0 (en) | Treatment | |
GB202002711D0 (en) | Treatment | |
GB202016957D0 (en) | Beneficial treatment | |
GB202114373D0 (en) | Treatment | |
GB202109815D0 (en) | Treatment | |
GB202109812D0 (en) | Treatment | |
GB202104666D0 (en) | COVID-19 treatment | |
GB202104416D0 (en) | Treatment reginmens | |
GB202103957D0 (en) | Treatment | |
GB202102488D0 (en) | Treatment | |
GB202102410D0 (en) | Treatment | |
GB202102373D0 (en) | Treatment | |
GB202102369D0 (en) | Treatment | |
GB202102366D0 (en) | Treatment | |
GB202101897D0 (en) | Treatment | |
GB202101875D0 (en) | Treatment | |
GB202101212D0 (en) | Treatment | |
GB202101211D0 (en) | Treatment | |
GB202101210D0 (en) | Treatment | |
GB202101213D0 (en) | Treatment | |
GB202100976D0 (en) | Treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |